The Role of the Estimated Plasma Volume Variation in Assessing Decongestion in Patients with Acute Decompensated Heart Failure
Introduction and Aim: Assessing decongestion in patients with acute decompensated heart failure (ADHF) is challenging, requiring multiple parameters and often remaining imprecise. The study aimed to investigate the utility of indirectly estimating plasma variation (∆ePVS) for evaluating decongestion...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/1/88 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832588981630402560 |
|---|---|
| author | Andreea-Maria Grigore Mihai Grigore Ana-Maria Balahura Gabriela Uscoiu Ioana Verde Camelia Nicolae Elisabeta Bădilă Adriana-Mihaela Ilieșiu |
| author_facet | Andreea-Maria Grigore Mihai Grigore Ana-Maria Balahura Gabriela Uscoiu Ioana Verde Camelia Nicolae Elisabeta Bădilă Adriana-Mihaela Ilieșiu |
| author_sort | Andreea-Maria Grigore |
| collection | DOAJ |
| description | Introduction and Aim: Assessing decongestion in patients with acute decompensated heart failure (ADHF) is challenging, requiring multiple parameters and often remaining imprecise. The study aimed to investigate the utility of indirectly estimating plasma variation (∆ePVS) for evaluating decongestion in ADHF patients in relation to natriuretic peptides. Materials and Methods: This prospective, observational, single-center study included 111 patients (mean age 74 years, 40% female) hospitalized with ADHF and treated with intravenous diuretics along with optimized medical therapy. Patients were clinically and echocardiographically evaluated at admission, with blood tests performed at both admission and discharge. A decrease of ≥30% in NT-proBNP at discharge was considered a marker of decongestion. ∆ePVS was calculated using the Strauss formula: ∆ePVS (%) = 100 × [(Hb admission/Hb discharge) × (1 − Hct discharge)/(1 − Hct admission)] − 100. A negative ∆ePVS (<0%) at discharge was considered a marker of hemoconcentration. Patients were divided into two groups: G1 (∆ePVS < 0%, 81 patients) and G2 (∆ePVS ≥ 0%, 30 patients). Results: Both groups had similar left ventricular ejection fraction (LVEF) values of 46%, mean hemoglobin (Hb) (12 g/dL), and creatinine (1.16 ± 0.65 mg/dL). NT-proBNP decreased in 88% patients in G1 and in 26% patients in G2 (<i>p</i> < 0.001). During hospitalization, five patients from G2 died. At 6 months, rehospitalization occurred in 35% of G2 and 21% of G1 (<i>p</i> = 0.04), with mortality rates of 37% in G2 and 11% in G1 (<i>p</i> = 0.012). Multivariate regression identified ∆ePVS as the only significant predictor of NT-proBNP decrease (OR 0.11, 95% CI 0.04–0.33, <i>p</i> < 0.001). Conclusions: Indirect estimation of plasma volume and its variation are valuable, accessible, and cost-effective parameters for assessing decongestive treatment in ADHF patients, complementing natriuretic peptides. |
| format | Article |
| id | doaj-art-76f004402dd24dcb9090dd3413cfa20c |
| institution | Kabale University |
| issn | 2227-9059 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Biomedicines |
| spelling | doaj-art-76f004402dd24dcb9090dd3413cfa20c2025-01-24T13:23:58ZengMDPI AGBiomedicines2227-90592025-01-011318810.3390/biomedicines13010088The Role of the Estimated Plasma Volume Variation in Assessing Decongestion in Patients with Acute Decompensated Heart FailureAndreea-Maria Grigore0Mihai Grigore1Ana-Maria Balahura2Gabriela Uscoiu3Ioana Verde4Camelia Nicolae5Elisabeta Bădilă6Adriana-Mihaela Ilieșiu7Department Cardio-Thoracic Pathology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, RomaniaDepartment Cardio-Thoracic Pathology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, RomaniaDepartment Cardio-Thoracic Pathology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, RomaniaDepartment Cardio-Thoracic Pathology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, RomaniaDepartment Cardio-Thoracic Pathology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, RomaniaDepartment Cardio-Thoracic Pathology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, RomaniaDepartment Cardio-Thoracic Pathology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, RomaniaDepartment Cardio-Thoracic Pathology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, RomaniaIntroduction and Aim: Assessing decongestion in patients with acute decompensated heart failure (ADHF) is challenging, requiring multiple parameters and often remaining imprecise. The study aimed to investigate the utility of indirectly estimating plasma variation (∆ePVS) for evaluating decongestion in ADHF patients in relation to natriuretic peptides. Materials and Methods: This prospective, observational, single-center study included 111 patients (mean age 74 years, 40% female) hospitalized with ADHF and treated with intravenous diuretics along with optimized medical therapy. Patients were clinically and echocardiographically evaluated at admission, with blood tests performed at both admission and discharge. A decrease of ≥30% in NT-proBNP at discharge was considered a marker of decongestion. ∆ePVS was calculated using the Strauss formula: ∆ePVS (%) = 100 × [(Hb admission/Hb discharge) × (1 − Hct discharge)/(1 − Hct admission)] − 100. A negative ∆ePVS (<0%) at discharge was considered a marker of hemoconcentration. Patients were divided into two groups: G1 (∆ePVS < 0%, 81 patients) and G2 (∆ePVS ≥ 0%, 30 patients). Results: Both groups had similar left ventricular ejection fraction (LVEF) values of 46%, mean hemoglobin (Hb) (12 g/dL), and creatinine (1.16 ± 0.65 mg/dL). NT-proBNP decreased in 88% patients in G1 and in 26% patients in G2 (<i>p</i> < 0.001). During hospitalization, five patients from G2 died. At 6 months, rehospitalization occurred in 35% of G2 and 21% of G1 (<i>p</i> = 0.04), with mortality rates of 37% in G2 and 11% in G1 (<i>p</i> = 0.012). Multivariate regression identified ∆ePVS as the only significant predictor of NT-proBNP decrease (OR 0.11, 95% CI 0.04–0.33, <i>p</i> < 0.001). Conclusions: Indirect estimation of plasma volume and its variation are valuable, accessible, and cost-effective parameters for assessing decongestive treatment in ADHF patients, complementing natriuretic peptides.https://www.mdpi.com/2227-9059/13/1/88heart failuredecongestionplasma volume |
| spellingShingle | Andreea-Maria Grigore Mihai Grigore Ana-Maria Balahura Gabriela Uscoiu Ioana Verde Camelia Nicolae Elisabeta Bădilă Adriana-Mihaela Ilieșiu The Role of the Estimated Plasma Volume Variation in Assessing Decongestion in Patients with Acute Decompensated Heart Failure Biomedicines heart failure decongestion plasma volume |
| title | The Role of the Estimated Plasma Volume Variation in Assessing Decongestion in Patients with Acute Decompensated Heart Failure |
| title_full | The Role of the Estimated Plasma Volume Variation in Assessing Decongestion in Patients with Acute Decompensated Heart Failure |
| title_fullStr | The Role of the Estimated Plasma Volume Variation in Assessing Decongestion in Patients with Acute Decompensated Heart Failure |
| title_full_unstemmed | The Role of the Estimated Plasma Volume Variation in Assessing Decongestion in Patients with Acute Decompensated Heart Failure |
| title_short | The Role of the Estimated Plasma Volume Variation in Assessing Decongestion in Patients with Acute Decompensated Heart Failure |
| title_sort | role of the estimated plasma volume variation in assessing decongestion in patients with acute decompensated heart failure |
| topic | heart failure decongestion plasma volume |
| url | https://www.mdpi.com/2227-9059/13/1/88 |
| work_keys_str_mv | AT andreeamariagrigore theroleoftheestimatedplasmavolumevariationinassessingdecongestioninpatientswithacutedecompensatedheartfailure AT mihaigrigore theroleoftheestimatedplasmavolumevariationinassessingdecongestioninpatientswithacutedecompensatedheartfailure AT anamariabalahura theroleoftheestimatedplasmavolumevariationinassessingdecongestioninpatientswithacutedecompensatedheartfailure AT gabrielauscoiu theroleoftheestimatedplasmavolumevariationinassessingdecongestioninpatientswithacutedecompensatedheartfailure AT ioanaverde theroleoftheestimatedplasmavolumevariationinassessingdecongestioninpatientswithacutedecompensatedheartfailure AT camelianicolae theroleoftheestimatedplasmavolumevariationinassessingdecongestioninpatientswithacutedecompensatedheartfailure AT elisabetabadila theroleoftheestimatedplasmavolumevariationinassessingdecongestioninpatientswithacutedecompensatedheartfailure AT adrianamihaelailiesiu theroleoftheestimatedplasmavolumevariationinassessingdecongestioninpatientswithacutedecompensatedheartfailure AT andreeamariagrigore roleoftheestimatedplasmavolumevariationinassessingdecongestioninpatientswithacutedecompensatedheartfailure AT mihaigrigore roleoftheestimatedplasmavolumevariationinassessingdecongestioninpatientswithacutedecompensatedheartfailure AT anamariabalahura roleoftheestimatedplasmavolumevariationinassessingdecongestioninpatientswithacutedecompensatedheartfailure AT gabrielauscoiu roleoftheestimatedplasmavolumevariationinassessingdecongestioninpatientswithacutedecompensatedheartfailure AT ioanaverde roleoftheestimatedplasmavolumevariationinassessingdecongestioninpatientswithacutedecompensatedheartfailure AT camelianicolae roleoftheestimatedplasmavolumevariationinassessingdecongestioninpatientswithacutedecompensatedheartfailure AT elisabetabadila roleoftheestimatedplasmavolumevariationinassessingdecongestioninpatientswithacutedecompensatedheartfailure AT adrianamihaelailiesiu roleoftheestimatedplasmavolumevariationinassessingdecongestioninpatientswithacutedecompensatedheartfailure |